gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Dec 2016.

Chromodomain helicase DNA binding protein 9

Top mentioned proteins: Chordin, Osteocalcin, ATPase, CHIP, BRG1
Papers on CHD9
New Face for Chromatin-Related Mesenchymal Modulator: n-CHD9 Localizes to Nucleoli and Interacts With Ribosomal Genes.
Hager et al., Tel Aviv-Yafo, Israel. In J Cell Physiol, Sep 2015
The Chromatin-Related Mesenchymal Modulator, CHD9 demonstrated in vitro its ability for remodeling activity to reposition nucleosomes in an ATP-dependent manner.
Genetic and expressional alterations of CHD genes in gastric and colorectal cancers.
Lee et al., Seoul, South Korea. In Histopathology, 2011
The aim was to determine the CHD1, CHD2, CHD3, CHD4, CHD7, CHD8 and CHD9 mutational status of mononucleotide repeats in gastric and colorectal cancers with microsatellite instability (MSI).
The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma.
Hsieh et al., Taipei, Taiwan. In Eur J Cancer, 2009
Of the four genes (CHD9, RBL2, AKTIP and RPGRIP1L) located in this region, only RPGRIP1L was downregulated in HCCs.
Insights on the functional role of chromatin remodelers in osteogenic cells.
Shur et al., Tel Aviv-Yafo, Israel. In Crit Rev Eukaryot Gene Expr, 2006
This review specifically highlights the role of the protein chromatin-related mesenchymal modulator (CReMM/CHD9), a recently identified chromatin remodeler, in osteogenic cell differentiation.
Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy.
Sorrentino et al., Memphis, United States. In Proc Natl Acad Sci U S A, 2006
Ligation-mediated PCR analysis showed integration sites near or within established protooncogenes (Chd9, Slamf6, Tde1, Camk2b, and Ly6e), demonstrating that T cell transformation was associated with targeting of oncogene loci; however, no integrations within the Lmo2 locus were identified.
Expression and regulation of CReMM, a chromodomain helicase-DNA-binding (CHD), in marrow stroma derived osteoprogenitors.
Benayahu et al., Tel Aviv-Yafo, Israel. In J Cell Physiol, 2006
CReMM is a chromodomain helicase-DNA-binding protein expressed by osteoprogenitors[CReMM]
PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex.
Reddy et al., Chicago, United States. In Biochem Biophys Res Commun, 2006
SDS-PAGE and matrix-assisted laser desorption/ionization reflection time-of-flight mass spectrometric analyses of ciprofibrate-binding proteins from liver nuclear extracts obtained using ciprofibrate-Sepharose affinity matrix resulted in the identification of a new high molecular weight nuclear receptor coactivator, which we designated PRIC320.
Dynamic interactions of chromatin-related mesenchymal modulator, a chromodomain helicase-DNA-binding protein, with promoters in osteoprogenitors.
Benayahu et al., Tel Aviv-Yafo, Israel. In Stem Cells, 2006
Chromatin immunoprecipitation assay was applied to follow the dynamics of CReMM binding to A/T-rich regions on promoters of genes that play a role in osteoblast maturation.
In vivo association of CReMM/CHD9 with promoters in osteogenic cells.
Benayahu et al., Tel Aviv-Yafo, Israel. In J Cell Physiol, 2006
Results imply that in osteogenic cells CReMM/CHD9 selectively interacts with promoters activated in the tissue at the appropriate time of embryonic development.
Characterization and functional analysis of CReMM, a novel chromodomain helicase DNA-binding protein.
Benayahu et al., Tel Aviv-Yafo, Israel. In J Mol Biol, 2005
The CHD9 (CReMM) protein is extensively phosphorylated, has DNA-dependent ATPase activity, and binds to A/T-rich DNA. It is also expressed in mesenchymal progenitors.
share on facebooktweetadd +1mail to friends